About us

AtG Therapeutics is a pre-clinical stage drug development company specialized in the discovery of tumor vulnerabilities and the development of therapeutics and biomarkers to treat advanced cancer.

Build a pipeline of tumor adaptation 
inhibitors and biomarkers  
to stop cancer growth over time


The novelty and the potential impact of the AtG project has been recognized by several entities at a national and international level.

European Research Council (ERC)

Learn more